loader2
Partner With Us NRI

Company details

608.75
630.75
583.05
1,193.00
6M Return -34.30%
1Y Return -45.62%
Mkt Cap.(Cr) 28,404.69
Volume 78,654
Div Yield 0.64%
OI
-
OI Chg %
-
Volume 78,654

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Our Research View

Trading recommendation

Data not found

Investment recommendation

Call Date

23 May 2022

Entry Price

635.00

Target Price

610.00

Duration

12-18 Month

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 13,803.09 Cr FV: 2.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 20,245.34 -48,746.54
LAST 3M 72,514.10 -88,466.89
LAST 6M 139,386.11 -218,253.53
LAST 12M 231,426.55 -250,977.27

Information

  • About Company
  • Company Info
  • Listing Info
0
46.78%
267.3266
9.16%
9.32%
Description
  • Lupin Ltd is in the Pharmaceuticals sector with the Market Capitalization of worth Rs. 44,266.89 crores, it is incorporated in the year 1968. It has a reported consolidated sales of Rs. 4,237.39 crores in June’2021. The company is also listed in the Bombay Stock Exchange (BSE) with the code 500257 and also listed in the National Stock Exchange (NSE) with the code LUPIN.

    Lupin Ltd is an Indian international pharmaceuticals company and is one of the largest generic pharmaceuticals companies globally based on revenue. The company primarily focuses on six areas, namely, paediatrics, cardiovascular, anti-infectives, diabetology, asthma, and anti- tuberculosis. Lupin has a global presence with operations spreading across 11 nations and 6 continents. Lupin has a team of over 1400 scientists working at Research 7 development headquarters located near Pune. Lupin ltd meets its corporate social responsibility through The Lupin Human Welfare & Research Foundation set up in 1988. The foundation mainly focuses on rural development projects that have reached over 3400 villages across eight states in the country to date. The promoters of the company own 46.84% of the stake in the company, Foreign Institutional Investors (FII) own 18.6%, Domestic Institutional Investors (DII) own 22.09% of the stake, and others (such as retail investors) hold the balance of 12.47%.

    In June 2021, quarterly net revenue was Rs. 3,314.12 crores, which has increased by approximately 22.97 % from Rs. 2,695.08 crores for the April-June 2020 quarter. The quarterly net profit in June 2021 was Rs. 645.87 crores, which has seen an increase by nearly 77.64 % from a net profit of Rs. 363.58 crores in June 2020. In June 2021, the reported operating profit was at Rs. 2,617.15 crores, which is also increased by 26.76% as compared to an operating profit of Rs. 2,064.73 crores for the quarter ending in June 2020. From Rs. 8.03 in June 2020, the EPS of Lupin Ltd has almost doubled and reached Rs. 14.13 per share in June 2021. LUPIN’s stock closed at Rs. 974.10 on 17th August’2021 (NSE) and has returned -8.29% in the last six months and -2.83% in the previous year.

Read More

No Data Found

AGM Date (Month) : Aug
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 500257
NSE Code : LUPIN
Book Closure Date (Month) :
BSE Group : A
ISIN : INE326A01037

ICICIdirect Lupin Ltd FAQ

You can buy Lupin Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Lupin Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jul 01, 2022 04:01 PM the closing price of Lupin Ltd was ₹ 625.00.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Jul 01, 2022 04:01 PM, the market cap of Lupin Ltd stood at ₹ 28,404.69.
The latest PE ratio of Lupin Ltd as of Jul 01, 2022 04:01 PM is 0
The latest PB ratio of Lupin Ltd as of Jul 01, 2022 04:01 PM is 0.43
The 52-week high of Lupin Ltd is ₹ 1,193.00 while the 52-week low is ₹ 583.05 .
According to analyst recommendations, Lupin Ltd has a “Buy” rating for the long term.

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE